BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1154275)

  • 21. [Immunohistologic determination of a tumor marker (CEA) in diseases of the gastrointestinal tract].
    Teuber J; Meier S; Aigner K; Helmke K; Paul F; Federlin K
    Immun Infekt; 1983 May; 11(3):91-8. PubMed ID: 6373575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of thymectomy on leukocyte migration inhibition test in myasthenia gravis and ulcerative colitis.
    Oda Y; Morisane T; Mizuno Y; Asakura H; Tsuchiya M
    Keio J Med; 1975 Dec; 24(4):289-96. PubMed ID: 1228265
    [No Abstract]   [Full Text] [Related]  

  • 23. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
    Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
    J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte subpopulation in neoplastic and non-neoplastic thymus and in blood of patients with Myasthenia gravis.
    Shirai T; Miyata M; Nakase A; Itoh T
    Clin Exp Immunol; 1976 Oct; 26(1):118-23. PubMed ID: 1087211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proceedings: CEA estimation in ulcerative colitis with and without malignant change.
    Dilawari JB; Lennard-Jones JE
    Gut; 1974 Oct; 15(10):828. PubMed ID: 4434941
    [No Abstract]   [Full Text] [Related]  

  • 26. CEA levels in fluids bathing gastrointestinal tumors.
    Molnar IG; Vandevoorde JP; Gitnick GL
    Gastroenterology; 1976 Apr; 70(4):513-5. PubMed ID: 1254136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Carcinoembryonic antigen (CEA) test in ulcerative colitis and Crohn's disease. A prospective clinical investigation].
    Knudsen L; Siemssen O
    Ugeskr Laeger; 1975 Jul; 137(31):1775-8. PubMed ID: 1154524
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
    Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
    Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
    Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymic lymphocytes in myasthenia gravis.
    Birnbaum G; Tsairis P
    Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perivascular infiltrate of memory lymphocytes and mature dendritic cells in MG thymomas.
    Nagane Y; Utsugisawa K; Akutsu H; Sato Y; Terayama Y
    Neurology; 2005 Sep; 65(5):770-2. PubMed ID: 16157920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
    Reinhardt C; Melms A
    Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of carcinoembryonic antigen activity of whole and extracted serum in ulcerative colitis.
    Khoo SK; Hunt PS; Mackay IR
    Gut; 1973 Jul; 14(7):545-8. PubMed ID: 4354145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera of patients with myasthenia gravis using indirect hemagglutination].
    Ma W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):143-5, 189. PubMed ID: 2390884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy.
    Sun Y; Qiao J; Lu CZ; Zhao CB; Zhu XM; Xiao BG
    Clin Immunol; 2004 Sep; 112(3):284-9. PubMed ID: 15308122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis: mitotic activity of thymus-dependent and blood-lymphocytes.
    Szobor A; Staub M; Szathmáry I; Csuka I; Antoni F
    Acta Med Acad Sci Hung; 1976; 33(1):25-39. PubMed ID: 1088241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in clinical and immunological status after post-thymectomized irradiation for invasive thymoma with myasthenia gravis].
    Ishida S
    Rinsho Shinkeigaku; 1996 May; 36(5):629-32. PubMed ID: 8905980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer.
    Sugarbaker PH; Bloomer WD; Corbett ED; Chaffey JT
    AJR Am J Roentgenol; 1976 Oct; 127(4):641-4. PubMed ID: 970537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Faecal carcinoembryonic antigen (CEA) in patients with large bowel cancer.
    Stubbs RS; Nadkarni DM; Monsey HA
    Eur J Surg Oncol; 1987 Oct; 13(5):433-6. PubMed ID: 3666160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.